DrugCard is a reliable partner in local literature screening for the pharmaceutical industry. This advanced AI tool is designed to simplify drug safety procedures, guaranteeing adherence to regulatory standards, while providing openness and traceability.

Key Features and Capabilities:

• Continuous Screening: Keep up-to-date with the latest local literature in your pharmaceutical markets through regular, automated screening.
• Transparency: Monitor and track the screening process to ensure accuracy, completeness, and comprehensive coverage.
• Scalability: Broaden your pharmaceutical operations globally with support for new markets, multiple languages, and suppliers.
• Cost-Effective: Achieve cost savings by avoiding hefty capital investments, making DrugCard an efficient option for pharmaceutical companies.
• Global Coverage: Access medical journals from over 35 countries in more than 100 languages, ensuring thorough screening.
• User-Friendly: Tailored for various pharmaceutical users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers.

User Benefits:

• Efficiency: Manage more projects and enhance screening outcomes with DrugCard, saving precious time and resources.
• Risk Mitigation: Perform in-house screening to mitigate compliance and reputation risks for MAHs.
• Cost Savings: Freelancers can optimize their time by automating literature screening and focusing on value-added tasks.
• Global Expansion: Easily expand pharmaceutical operations into new markets with DrugCard's scalability and global coverage.
• Reliability: Trust in DrugCard's high accuracy rate for scanned PDF screening.

Summary: DrugCard is the premier solution for local literature screening in the pharmaceutical industry. By offering continuous screening, transparency, scalability, and cost-effectiveness, it enables pharmaceutical companies, CROs, MAHs, and freelancers to streamline drug safety processes, meet regulatory requirements, and ensure compliance with confidence.